Worldwide Healthcare (WWH)

Category Sector Equity Healthcare

star-filledstar-filled
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

282.50p

Buy

284.00p

arrow-down-3.50p (-1.22%)

Discount/Premium

-11.48%

Estimated NAV

324.22p

Prices updated at 13 May 2025, 17:00 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Investment objective
In order to achieve a high level of capital growth, the Company invests in the global healthcare sector and in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing, and derivative transactions to mitigate risk and also to enhance returns.

arrow-up0.06%
LSE

Portfolio as of 30/04/2025

Asset allocation

Created with Highcharts 7.2.286.93% Stocks- Bonds5.33% Cash7.74% Other0% Not classified
Show long & short position

Geographical breakdown

Continent or country allocation (%)

Created with Highcharts 7.2.21.11.11.81.83.723.728.428.429.379.3775.5875.58Asia - DevelopedEurozoneJapanUnited KingdomAsia - EmergingUnited States

Market classification (%)

Created with Highcharts 7.2.29.379.3790.6390.63EmergingDeveloped

Top 10 holdings

Security nameSectorCountry% of assets
1Eli Lilly and Co-United States9.91
2Boston Scientific Corp-United States9.43
3AstraZeneca PLC-United Kingdom6.16
4Intuitive Surgical Inc-United States5.55
5Stryker Corp-United States4.59
6Tenet Healthcare Corp-United States3.73
7argenx SE ADR-United States3.32
8Edwards Lifesciences Corp-United States3.31
9Daiichi Sankyo Co Ltd-Japan3.16
10Neurocrine Biosciences Inc-United States3.16
Assets in top 10 holdings %

52.32%

Total no. of equity holdings

39.00

Total no. of bond holdings

-

Stock sectors

Worldwide Healthcare
Sector Equity Healthcare

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

0.00%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

-
-

100.00%

Con defensive

-
-

Healthcare

100.00%
-

Utilities

-
-


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.